This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

3 Biotech Stocks Spiking on Big Volume

Halozyme Therapeutics

Halozyme Therapeutics ((HALO - Get Report)), a biopharmaceutical company, engages in the research, development and commercialization of human enzymes. This stock closed up 16.6% at $14.75 in Wednesdays trading session.

Wednesdays Volume: 5.34 million
Three-Month Average Volume: 1.66 million
Volume % Change: 255%

From a technical perspective, HALO skyrocketed higher here right off its 50-day moving average of $12.74 with strong upside volume. This stock has been uptrending strong for the last four months and change, with shares moving higher from its low of $6.51 to its recent high of $15.39. During that uptrend, shares of HALO have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of HALO within range of triggering a near-term breakout trade. That trade will hit if HALO manages to take out Wednesday's high of $14.77 to its 52-week high at $15.39 with high volume.

Must Read: 5 Cash-Rich Stocks That Could Pay Triple the Gains in 2014

Traders should now look for long-biased trades in HALO as long as its trending above $14 or $13 and then once it sustains a move or close above those breakout levels with volume thats near or above 1.66 million shares. If that breakout hits soon, then HALO will set up to enter new 52-week-high territory above $15.39, which is bullish technical price action. Some possible upside targets off that breakout are $17 to $18, or even $20.

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ALXN $136.84 -3.80%
HALO $7.12 -9.90%
NPSP $45.97 0.02%
AAPL $93.55 -0.50%
FB $98.07 -5.80%


Chart of I:DJI
DOW 15,828.21 -376.76 -2.33%
S&P 500 1,834.56 -45.49 -2.42%
NASDAQ 4,233.2710 -129.8730 -2.98%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs